In future studies, we will build on the results presented here to identify a next generation native gene promoter that strongly responds to hypoxia by integrating diverse tissue “stress” signals and may thus show even better efficacy for MSC-directed theranostic NIS expression in diverse tumor settings. The gene discussed is SLC5A5; the disease is neoplasm.